跳至主要内容
临床试验/KCT0003610
KCT0003610已完成未知

Short-term Dual Antiplatelet Therapy after Deployment of Bioabsorbable Polymer Everolimus-eluting Stent

Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 1,452 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,452

研究概览

简要总结

This randomized clinical trial found that among patients with coronary artery disease undergoing PCI with the latest generation of drug-eluting stents, P2Y12 inhibitor monotherapy after 3-month DAPT was not inferior to 12-month DAPT for NACE. Further research is required to analyze the impact of this strategy on individual outcomes, including bleeding events.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1. Age 19+
  • 2. Patients treated with a new generation of Evelorimus-eluting stents (Synergy®)
  • 3. Patients who understand the content of the subject description and voluntarily sign the subject

排除标准

  • 1. Age 86+
  • 2. Hemodynamically unstable patient
  • 3. Severe hypersensitivity reactions to aspirin, clopidogrel, ticagrelor, everolimus, contrast agent
  • 4. Patients at high risk of bleeding, anemia, thrombocytopenia
  • 5. Patients requiring oral anticoagulants
  • 6. Pregnant women or women of childbearing age
  • 7. Life expectancy is less than one year
  • 8. Patients receiving a potent CYP3A4 inhibitor (eg, ketoconazole, clarithromycin, napjodone, ritonavir, atazanavir)
  • 9. Patients with a history of intracranial hemorrhage
  • 10. Patients with moderate to severe hepatic impairment
  • 11. Patients underwent coronary intervention with stenting within 1 year
  • 12. Patients with left-main lesions requiring coronary intervention
  • 13. Patients with chronic stricture lesions requiring treatment
  • 14. Patients with in-stent restenosis in a lesion requiring treatment
  • 15. Patients with bifurcation lesions requiring stenting in lateral branches
  • 16. Patients with lesions requiring more than 3 stents

研究者

发起方
Yonsei University Health System, Gangnam Severance Hospital

相似试验

Short-term Dual Antiplatelet Therapy after... | 临床试验